144 related articles for article (PubMed ID: 12890162)
1. Overexpression of p16INK4A and p14ARF in haematological malignancies.
Lee YK; Park JY; Kang HJ; Cho HC
Clin Lab Haematol; 2003 Aug; 25(4):233-7. PubMed ID: 12890162
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of p16INK4A and p14ARF in haematological malignancies.
Güran S; Beyan C
Clin Lab Haematol; 2004 Aug; 26(4):303. PubMed ID: 15279671
[No Abstract] [Full Text] [Related]
3. Expression of p16INK4A and p14ARF in hematological malignancies.
Taniguchi T; Chikatsu N; Takahashi S; Fujita A; Uchimaru K; Asano S; Fujita T; Motokura T
Leukemia; 1999 Nov; 13(11):1760-9. PubMed ID: 10557050
[TBL] [Abstract][Full Text] [Related]
4. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
[TBL] [Abstract][Full Text] [Related]
5. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms.
Silva J; Silva JM; Domínguez G; García JM; Cantos B; Rodríguez R; Larrondo FJ; Provencio M; España P; Bonilla F
J Pathol; 2003 Mar; 199(3):289-97. PubMed ID: 12579530
[TBL] [Abstract][Full Text] [Related]
6. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
[TBL] [Abstract][Full Text] [Related]
7. Different p16INK4a and p14ARF expression patterns in acute myeloid leukaemia and normal blood leukocytes.
Tschan MP; Vonlanthen S; Cajot JF; Peters UR; Oppliger E; Betticher DC; Yarbrough WG; Fey MF; Tobler A
Leuk Lymphoma; 2001; 42(5):1077-87. PubMed ID: 11697625
[TBL] [Abstract][Full Text] [Related]
8. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
[TBL] [Abstract][Full Text] [Related]
9. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between alterations of p16INK4a and p14ARF genes of CDKN2A locus and gastric carcinogenesis].
Tang SH; Yang DH; Luo HS; Yu JP; Shu JC
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):517-21. PubMed ID: 15231134
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
[TBL] [Abstract][Full Text] [Related]
12. FBXL16 is a novel E2F1-regulated gene commonly upregulated in p16INK4A- and p14ARF-silenced HeLa cells.
Sato K; Kusama Y; Tategu M; Yoshida K
Int J Oncol; 2010 Feb; 36(2):479-90. PubMed ID: 20043084
[TBL] [Abstract][Full Text] [Related]
13. Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer.
Silva J; Domínguez G; Silva JM; García JM; Gallego I; Corbacho C; Provencio M; España P; Bonilla F
Oncogene; 2001 Jul; 20(33):4586-90. PubMed ID: 11494155
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the p16INK4a/p14ARF pathway in clear cell sarcoma.
Takahira T; Oda Y; Tamiya S; Yamamoto H; Kawaguchi K; Kobayashi C; Iwamoto Y; Tsuneyoshi M
Cancer Sci; 2004 Aug; 95(8):651-5. PubMed ID: 15298727
[TBL] [Abstract][Full Text] [Related]
15. p14ARF, p15INK4b and p16INK4a methylation status in chronic myelogenous leukemia.
Kusy S; Larsen CJ; Roche J
Leuk Lymphoma; 2004 Oct; 45(10):1989-94. PubMed ID: 15370242
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma.
Venza M; Visalli M; Biondo C; Lentini M; Catalano T; Teti D; Venza I
Biochim Biophys Acta; 2015 Mar; 1849(3):247-56. PubMed ID: 25497382
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
18. Effects of CDKN2A (p16INK4A/p14ARF) Over-Expression on Proliferation and Migration of Human Melanoma A375 Cells.
Bai M; Yu NZ; Long F; Feng C; Wang XJ
Cell Physiol Biochem; 2016; 40(6):1367-1376. PubMed ID: 27997910
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type.
Tsujimoto H; Hagiwara A; Sugihara H; Hattori T; Yamagishi H
Pathol Res Pract; 2002; 198(12):785-94. PubMed ID: 12608655
[TBL] [Abstract][Full Text] [Related]
20. Lower expression of p14ARF and p16INK4a correlates with higher DNMT3B expression in human oesophageal squamous cell carcinomas.
Simão Tde A; Simões GL; Ribeiro FS; Cidade DA; Andreollo NA; Lopes LR; Macedo JM; Acatauassu R; Teixeira AM; Felzenszwalb I; Pinto LF; Albano RM
Hum Exp Toxicol; 2006 Sep; 25(9):515-22. PubMed ID: 17017004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
